Insulin glargine/lixisenatide
Insulin glargine/lixisenatide
Insulin glargine/lixisenatide (pronunciation: IN-su-lin GLAR-geen/LIX-i-SEN-a-tide) is a combination medication used in the treatment of Type 2 diabetes.
Etymology
The term "insulin" is derived from the Latin insula, meaning "island", referring to the insulin-producing islets of Langerhans in the pancreas. "Glargine" is a portmanteau of "glarg" (an arbitrary root) and "-ine" (a common suffix for insulins). "Lixisenatide" is a synthetic derivative of exendin-4, a hormone found in the saliva of the Gila monster.
Usage
Insulin glargine/lixisenatide is used to improve blood sugar control in adults with Type 2 diabetes. This is done by providing both a long-acting insulin (insulin glargine) and a glucagon-like peptide-1 (GLP-1) receptor agonist (lixisenatide).
Related Terms
- Insulin: A hormone that regulates the amount of glucose in the blood.
- Lixisenatide: A glucagon-like peptide-1 receptor agonist used in the treatment of diabetes.
- Glucagon-like peptide-1: A hormone that stimulates insulin secretion.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
Side Effects
Common side effects of insulin glargine/lixisenatide include hypoglycemia (low blood sugar), allergic reactions, and gastrointestinal problems.
See Also
External links
- Medical encyclopedia article on Insulin glargine/lixisenatide
- Wikipedia's article - Insulin glargine/lixisenatide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski